Company research
Venus Concept Inc.
CIK 1409269Updated Oct 6, 2026
Historical securities (2)
VERO · NASDAQ · equity · closed Feb 6, 2026VERO · OTC · equity · closed Apr 6, 2026VERO price & chart
This listing closed Feb 6, 2026. Live provider charts are shown only for current listings.
About the company
Venus Concept is an innovative global medical aesthetic technology leader with a broad product portfolio of minimally invasive and non-invasive medical aesthetic and hair restoration technologies and reaches over 60 countries and 9 direct markets. Venus Concept's product portfolio consists of aesthetic device platforms, including Venus NOVA, Venus Versa, Venus Versa PRO, Venus Bliss, Venus Bliss MAX, Venus Viva, Venus Viva MD, Venus Legacy, Venus Velocity, Venus Epileve and AI. ME. Venus Concept's hair restoration systems include NeoGraft® and the ARTAS iX® Robotic Hair Restoration system. Venus Concept has been backed by leading healthcare industry growth equity investors including EW Healthcare Partners (formerly Essex Woodlands), HealthQuest Capital, Longitude Capital Management, Aperture Venture Partners, Masters Special Situations, and Madryn Asset Management, L.P.
In the news
No coverage from other publishers is available.
Financials
FY 2024 · USDSource
Source
Source
Source
Source
balance sheet · annual statements
| Line item | Q3 2025 | Q3 2024 | Q3 2023 | Q2 2025 | Q2 2024 | Q2 2023 | Q1 2025 | Q1 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| AssetsUSD | 61,624,000Source | 72,276,000Source | 98,921,000Source | 63,085,000Source | 79,750,000Source | 106,156,000Source | 63,460,000Source | 85,076,000Source | 68,184,000Source | 93,654,000Source | 125,378,000Source | 153,867,000Source |
| Property, Plant and Equipment, NetUSD | 866,000Source | 1,038,000Source | 1,503,000Source | 940,000Source | 1,126,000Source | 1,640,000Source | 851,000Source | 1,229,000Source | 936,000Source | 1,322,000Source | 1,857,000Source | 2,669,000Source |
| Intangible Assets, Net (Excluding Goodwill)USD | 2,375,000Source | 5,846,000Source | 9,321,000Source | 3,250,000Source | 6,719,000Source | 10,197,000Source | 4,116,000Source | 7,582,000Source | 4,973,000Source | 8,446,000Source | 11,919,000Source | 15,393,000Source |
| Current assets: | ||||||||||||
| Cash and Cash Equivalents, at Carrying ValueUSD | 4,312,000Source | 4,489,000Source | 4,926,000Source | 3,878,000Source | 5,732,000Source | 6,122,000Source | 3,199,000Source | 5,087,000Source | 4,271,000Source | 5,396,000Source | 11,569,000Source | 30,876,000Source |
| Accounts Receivable, after Allowance for Credit Loss, CurrentUSD | 16,503,000Source | 21,102,000Source | 34,178,000Source | 15,767,000Source | 24,584,000Source | 37,520,000Source | 16,782,000Source | 27,168,000Source | 18,721,000Source | 29,151,000Source | 37,262,000Source | 46,918,000Source |
| Inventory, NetUSD | 15,768,000Source | 18,904,000Source | 23,392,000Source | 15,860,000Source | 19,782,000Source | 22,936,000Source | 17,633,000Source | 20,978,000Source | 17,561,000Source | 23,072,000Source | 23,906,000Source | 20,543,000Source |
| Assets, CurrentUSD | 45,824,000Source | 51,218,000Source | 71,767,000Source | 45,108,000Source | 56,903,000Source | 75,792,000Source | 45,605,000Source | 60,701,000Source | 48,512,000Source | 66,446,000Source | 84,008,000Source | 106,994,000Source |
| Operating Lease, Right-of-Use AssetUSD | 2,465,000Source | 3,591,000Source | 4,647,000Source | 2,684,000Source | 3,907,000Source | 4,983,000Source | 3,079,000Source | 4,081,000Source | 3,282,000Source | 4,517,000Source | 5,862,000Source | — |
| LIABILITIES AND EQUITY | ||||||||||||
| LiabilitiesUSD | 58,490,000Source | 61,648,000Source | 110,299,000Source | 60,313,000Source | 75,386,000Source | 111,698,000Source | 60,732,000Source | 106,988,000Source | 65,346,000Source | 107,103,000Source | 116,640,000Source | 112,271,000Source |
| Stockholders’ equity: | ||||||||||||
| Common Stock, Value, IssuedUSD | 31,000Source | 30,000Source | 30,000Source | 31,000Source | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 30,000Source | 29,000Source | 27,000Source |
| Retained Earnings (Accumulated Deficit)USD | -355,548,000Source | -300,934,000Source | -250,787,000Source | -332,983,000Source | -291,648,000Source | -241,719,000Source | -321,262,000Source | -271,697,000Source | -308,899,000Source | -261,903,000Source | -224,105,000Source | -180,405,000Source |
| Stockholders' Equity Attributable to ParentUSD | 2,673,000Source | 10,108,000Source | -12,170,000Source | 2,327,000Source | 3,702,000Source | -6,222,000Source | 2,262,000Source | -22,487,000Source | 2,369,000Source | -14,019,000Source | 8,093,000Source | 40,943,000Source |
| Additional Paid in Capital, Common StockUSD | 358,190,000Source | 311,012,000Source | 238,587,000Source | 335,279,000Source | 295,320,000Source | 235,467,000Source | 323,494,000Source | 249,180,000Source | 311,238,000Source | 247,854,000Source | 232,169,000Source | 221,321,000Source |
| Liabilities and EquityUSD | 61,624,000Source | 72,276,000Source | 98,921,000Source | 63,085,000Source | 79,750,000Source | 106,156,000Source | 63,460,000Source | 85,076,000Source | 68,184,000Source | 93,654,000Source | 125,378,000Source | 153,867,000Source |
| Current liabilities: | ||||||||||||
| Liabilities, CurrentUSD | 50,650,000Source | 27,467,000Source | 26,001,000Source | 41,118,000Source | 28,538,000Source | 34,941,000Source | 35,609,000Source | 29,448,000Source | 30,287,000Source | 31,159,000Source | 39,595,000Source | 31,215,000Source |
| Operating Lease, Liability, CurrentUSD | 1,249,000Source | 1,407,000Source | 1,515,000Source | 1,238,000Source | 1,432,000Source | 1,571,000Source | 1,300,000Source | 1,418,000Source | 1,322,000Source | 1,590,000Source | 1,807,000Source | — |
| Operating Lease, Liability, NoncurrentUSD | 1,349,000Source | 2,333,000Source | 3,304,000Source | 1,538,000Source | 2,613,000Source | 3,666,000Source | 1,803,000Source | 2,846,000Source | 1,997,000Source | 3,162,000Source | 4,221,000Source | — |
| Deferred Income Tax Liabilities, NetUSD | — | 0Source | 20,000Source | — | 2,000Source | 6,000Source | — | 11,000Source | 0Source | 15,000Source | 0Source | 46,000Source |
| Other Liabilities, NoncurrentUSD | 388,000Source | 696,000Source | 336,000Source | 673,000Source | 664,000Source | 392,000Source | 725,000Source | 672,000Source | 511,000Source | 338,000Source | 215,000Source | 348,000Source |
| Stockholders' Equity Attributable to Noncontrolling InterestUSD | 461,000Source | 520,000Source | 792,000Source | 445,000Source | 662,000Source | 680,000Source | 466,000Source | 575,000Source | 469,000Source | 570,000Source | 645,000Source | 653,000Source |
| Additional Financial Items | ||||||||||||
| Accounts Receivable, after Allowance for Credit LossUSD | 24,408,000Source | 28,546,000Source | 41,920,000Source | 24,122,000Source | 32,427,000Source | 47,135,000Source | 23,826,000Source | 34,906,000Source | 25,984,000Source | 38,330,000Source | 53,952,000Source | 70,595,000Source |
| Accrued Liabilities, CurrentUSD | 4,617,000Source | 4,620,000Source | 4,950,000Source | 4,329,000Source | 4,890,000Source | 4,023,000Source | 3,491,000Source | 4,713,000Source | 3,552,000Source | 3,924,000Source | 5,045,000Source | 6,584,000Source |
| Long-term Debt, Excluding Current MaturitiesUSD | 4,996,000Source | 30,025,000Source | 79,049,000Source | 15,866,000Source | 42,402,000Source | 70,683,000Source | 21,565,000Source | 72,552,000Source | 31,437,000Source | 70,790,000Source | 70,003,000Source | 77,325,000Source |
cash flow · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2025 | Q1 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash flows from operating activities: | ||||||||||||
| Net Income (Loss), Including Portion Attributable to Noncontrolling InterestUSD | — | — | -22,549,000Source | -9,302,000Source | -11,742,000Source | -19,864,000Source | -12,366,000Source | -9,789,000Source | -46,971,000Source | -37,050,000Source | -43,584,000Source | -22,141,000Source |
| Adjustments to reconcile net income to net cash provided by operating activities: | ||||||||||||
| Depreciation, Depletion and AmortizationUSD | — | — | — | — | — | — | 950,000Source | 975,000Source | 3,889,000Source | 4,115,000Source | 4,463,000Source | 4,854,000Source |
| Share-based Payment Arrangement, Noncash ExpenseUSD | — | — | — | — | — | — | 207,000Source | 339,000Source | 1,043,000Source | 1,569,000Source | 2,104,000Source | 2,068,000Source |
| Changes in operating assets and liabilities: | ||||||||||||
| Increase (Decrease) in Accounts ReceivableUSD | — | — | — | — | — | — | -1,226,000Source | -3,226,000Source | -12,487,000Source | -14,891,000Source | -9,855,000Source | 869,000Source |
| Increase (Decrease) in InventoriesUSD | — | — | — | — | — | — | 641,000Source | -1,722,000Source | -4,463,000Source | 324,000Source | 5,783,000Source | 4,261,000Source |
| Deferred Income Tax Expense (Benefit)USD | — | — | — | — | — | — | 341,000Source | -120,000Source | -443,000Source | -69,000Source | -709,000Source | -165,000Source |
| Net Cash Provided by (Used in) Operating ActivitiesUSD | — | — | — | — | — | — | -6,310,000Source | -2,878,000Source | -11,066,000Source | -12,859,000Source | -26,980,000Source | -19,771,000Source |
| Cash flows from investing activities: | ||||||||||||
| Net Cash Provided by (Used in) Investing ActivitiesUSD | — | — | — | — | — | — | -35,000Source | -25,000Source | -123,000Source | -116,000Source | -336,000Source | -552,000Source |
| Payments to Acquire Property, Plant, and EquipmentUSD | — | — | — | — | — | — | 35,000Source | 25,000Source | 123,000Source | 116,000Source | 336,000Source | 512,000Source |
| Cash flows from financing activities: | ||||||||||||
| Net Cash Provided by (Used in) Financing ActivitiesUSD | — | — | — | — | — | — | 5,273,000Source | 2,594,000Source | 10,064,000Source | 6,802,000Source | 8,009,000Source | 16,819,000Source |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate EffectUSD | — | — | — | — | — | — | -1,072,000Source | -309,000Source | -1,125,000Source | -6,173,000Source | -19,307,000Source | -3,504,000Source |
| Supplemental disclosure of cash flow information: | ||||||||||||
| Interest Paid, Excluding Capitalized Interest, Operating ActivitiesUSD | — | — | — | — | — | — | 0Source | 1,187,000Source | 1,610,000Source | 4,473,000Source | 4,147,000Source | 3,292,000Source |
| Additional Financial Items | ||||||||||||
| Share-based Payment Arrangement, ExpenseUSD | — | — | 135,000Source | 239,000Source | 137,000Source | 239,000Source | 207,000Source | 339,000Source | 1,043,000Source | 1,569,000Source | 2,104,000Source | 2,068,000Source |
| Amortization of Debt Issuance Costs and DiscountsUSD | — | — | — | — | — | — | 1,634,000Source | 481,000Source | 5,391,000Source | 2,206,000Source | 414,000Source | 1,779,000Source |
| Amortization of Intangible AssetsUSD | — | — | 875,000Source | 873,000Source | 866,000Source | 863,000Source | 855,000Source | 864,000Source | 3,474,000Source | 3,473,000Source | 3,473,000Source | 3,473,000Source |
| DepreciationUSD | — | — | 101,000Source | 98,000Source | 89,000Source | 113,000Source | 93,000Source | 112,000Source | 415,000Source | 642,000Source | 990,000Source | 1,381,000Source |
| Financing Interest ExpenseUSD | — | — | 1,016,000Source | 1,665,000Source | 1,167,000Source | 2,452,000Source | 1,570,000Source | 1,668,000Source | 6,885,000Source | 6,893,000Source | 4,561,000Source | 4,955,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | 35,000Source | -57,000Source | 545,000Source | -774,000Source | 119,000Source | -324,000Source | -2,135,000Source | 295,000Source | -3,387,000Source | -2,559,000Source |
| Foreign Currency Transaction Gain (Loss), UnrealizedUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Gain (Loss) on Disposition of Property Plant EquipmentUSD | — | — | — | — | — | — | -27,000Source | -5,000Source | -93,000Source | -10,000Source | -158,000Source | 0Source |
| Gain (Loss) on Extinguishment of DebtUSD | — | — | -11,297,000Source | -454,000Source | -1,865,000Source | -10,901,000Source | -1,049,000Source | 0Source | -11,355,000Source | -2,040,000Source | — | — |
| General and Administrative ExpenseUSD | — | — | 9,647,000Source | 8,732,000Source | 9,433,000Source | 8,660,000Source | 9,735,000Source | 10,248,000Source | 36,470,000Source | 41,048,000Source | 49,618,000Source | 45,940,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Income Tax Expense (Benefit)USD | — | — | 531,000Source | -31,000Source | 214,000Source | 141,000Source | 338,000Source | 37,000Source | -611,000Source | -71,000Source | -722,000Source | -707,000Source |
| Inventory Write-downUSD | — | — | — | — | — | — | 569,000Source | 372,000Source | 1,804,000Source | 1,158,000Source | 2,420,000Source | 1,456,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -22,565,000Source | -9,286,000Source | -11,721,000Source | -19,951,000Source | -12,363,000Source | -9,794,000Source | -46,996,000Source | -37,250,000Source | -43,700,000Source | -23,013,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 16,000Source | -16,000Source | -21,000Source | 87,000Source | -3,000Source | 5,000Source | 25,000Source | 200,000Source | 116,000Source | 872,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -22,565,000Source | -9,286,000Source | -11,721,000Source | -19,951,000Source | -12,363,000Source | -9,794,000Source | -46,996,000Source | -37,250,000Source | -43,700,000Source | -23,013,000Source |
| Operating ExpensesUSD | — | — | 18,313,000Source | 17,078,000Source | 18,472,000Source | 17,445,000Source | 18,283,000Source | 19,407,000Source | 71,490,000Source | 80,476,000Source | 100,847,000Source | 88,861,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 2,187,000Source |
| Proceeds from Issuance of Common StockUSD | — | — | — | — | — | — | 0Source | 10,000Source | 10,000Source | 816,000Source | 2,135,000Source | 0Source |
| Proceeds from Stock Options ExercisedUSD | — | — | — | — | — | — | — | — | — | 0Source | 23,000Source | 354,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 13,776,000Source | 15,007,000Source | 15,692,000Source | 16,582,000Source | 13,643,000Source | 17,479,000Source | 64,833,000Source | 76,354,000Source | 99,497,000Source | 105,622,000Source |
| Unrealized Gain (Loss) on DerivativesUSD | — | — | 216,000Source | 0Source | 29,000Source | 0Source | -166,000Source | 618,000Source | 771,000Source | — | — | — |
| Income Taxes Paid, Net | — | — | — | — | — | — | — | — | — | — | — | — |
income statement · annual statements
| Line item | Q4 2024 | Q4 2023 | Q3 2025 | Q3 2024 | Q2 2025 | Q2 2024 | Q1 2025 | Q1 2024 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total RevenueUSD | — | — | 13,776,000Source | 15,007,000Source | 15,692,000Source | 16,582,000Source | 13,643,000Source | 17,479,000Source | 64,833,000Source | 76,354,000Source | 99,497,000Source | 105,622,000Source |
| Cost of RevenueUSD | — | — | 4,959,000Source | 5,086,000Source | 6,261,000Source | 4,733,000Source | 4,888,000Source | 5,832,000Source | 20,527,000Source | 24,187,000Source | 33,526,000Source | 31,528,000Source |
| Operating Income (Loss)USD | — | — | -9,496,000Source | -7,157,000Source | -9,041,000Source | -5,596,000Source | -9,528,000Source | -7,760,000Source | -27,184,000Source | -28,309,000Source | -34,876,000Source | -14,767,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling InterestUSD | — | — | -22,018,000Source | -9,333,000Source | -11,528,000Source | -19,723,000Source | -12,028,000Source | -9,752,000Source | -47,582,000Source | -37,121,000Source | -44,306,000Source | -22,848,000Source |
| Income Tax Expense (Benefit)USD | — | — | 531,000Source | -31,000Source | 214,000Source | 141,000Source | 338,000Source | 37,000Source | -611,000Source | -71,000Source | -722,000Source | -707,000Source |
| Net Income (Loss) Attributable to Noncontrolling InterestUSD | — | — | 16,000Source | -16,000Source | -21,000Source | 87,000Source | -3,000Source | 5,000Source | 25,000Source | 200,000Source | 116,000Source | 872,000Source |
| Net Income (Loss) Attributable to ParentUSD | — | — | -22,565,000Source | -9,286,000Source | -11,721,000Source | -19,951,000Source | -12,363,000Source | -9,794,000Source | -46,996,000Source | -37,250,000Source | -43,700,000Source | -23,013,000Source |
| Earnings Per Share, BasicUSD per share | — | — | -12.14Source | -13.1Source | -8.03Source | -30.93Source | -17.44Source | -16.92Source | -71.21Source | -6.84Source | -0.66Source | -0.42Source |
| Earnings Per Share, DilutedUSD per share | — | — | -12.14Source | -13.1Source | -8.03Source | -30.93Source | -17.44Source | -16.92Source | -71.21Source | -6.84Source | -0.66Source | -0.42Source |
| Weighted Average Number of Shares Outstanding, Basicshares | — | — | 1,859,000Source | 709,000Source | 1,459,000Source | 645,000Source | 709,000Source | 579,000Source | 660,000Source | 5,442,000Source | 65,960,000Source | 54,466,000Source |
| Weighted Average Number of Shares Outstanding, Dilutedshares | — | — | 1,859,000Source | 709,000Source | 1,459,000Source | 645,000Source | 709,000Source | 579,000Source | 660,000Source | 5,442,000Source | 65,960,000Source | 54,466,000Source |
| Additional Financial Items | ||||||||||||
| Amortization of Intangible AssetsUSD | — | — | 875,000Source | 873,000Source | 866,000Source | 863,000Source | 855,000Source | 864,000Source | 3,474,000Source | 3,473,000Source | 3,473,000Source | 3,473,000Source |
| Current Income Tax Expense (Benefit)USD | — | — | — | — | — | — | — | — | -168,000Source | -2,000Source | -13,000Source | -542,000Source |
| Financing Interest ExpenseUSD | — | — | 1,016,000Source | 1,665,000Source | 1,167,000Source | 2,452,000Source | 1,570,000Source | 1,668,000Source | 6,885,000Source | 6,893,000Source | 4,561,000Source | 4,955,000Source |
| Foreign Currency Transaction Gain (Loss), RealizedUSD | — | — | 35,000Source | -57,000Source | 545,000Source | -774,000Source | 119,000Source | -324,000Source | -2,135,000Source | 295,000Source | -3,387,000Source | -2,559,000Source |
| General and Administrative ExpenseUSD | — | — | 9,647,000Source | 8,732,000Source | 9,433,000Source | 8,660,000Source | 9,735,000Source | 10,248,000Source | 36,470,000Source | 41,048,000Source | 49,618,000Source | 45,940,000Source |
| Goodwill, Impairment LossUSD | — | — | — | — | — | — | — | — | 0Source | 0Source | 0Source | 0Source |
| Gross ProfitUSD | — | — | 8,817,000Source | 9,921,000Source | 9,431,000Source | 11,849,000Source | 8,755,000Source | 11,647,000Source | 44,306,000Source | 52,167,000Source | 65,971,000Source | 74,094,000Source |
| Income (Loss) from Continuing Operations before Income Taxes, DomesticUSD | — | — | — | — | — | — | — | — | -35,667,000Source | -41,197,000Source | -32,045,000Source | -12,260,000Source |
| Interest Expense, DebtUSD | — | — | 1,146,000Source | 1,487,000Source | 1,110,000Source | 1,830,000Source | 1,320,000Source | 2,077,000Source | 6,469,000Source | 6,629,000Source | 4,297,000Source | 3,720,000Source |
| Net Income (Loss) Available to Common Stockholders, BasicUSD | — | — | -22,565,000Source | -9,286,000Source | -11,721,000Source | -19,951,000Source | -12,363,000Source | -9,794,000Source | -46,996,000Source | -37,250,000Source | -43,700,000Source | -23,013,000Source |
| Operating ExpensesUSD | — | — | 18,313,000Source | 17,078,000Source | 18,472,000Source | 17,445,000Source | 18,283,000Source | 19,407,000Source | 71,490,000Source | 80,476,000Source | 100,847,000Source | 88,861,000Source |
| Operating Lease, ExpenseUSD | — | — | — | — | — | — | — | — | — | — | — | 2,187,000Source |
| Preferred Stock Dividends, Income Statement ImpactUSD | — | — | — | — | — | — | — | — | — | — | — | 0Source |
| Research and Development ExpenseUSD | — | — | 1,280,000Source | 1,692,000Source | 1,354,000Source | 1,737,000Source | 1,556,000Source | 1,785,000Source | 6,688,000Source | 8,197,000Source | 10,953,000Source | 8,258,000Source |
| Revenue from Contract with Customer, Including Assessed TaxUSD | — | — | 13,776,000Source | 15,007,000Source | 15,692,000Source | 16,582,000Source | 13,643,000Source | 17,479,000Source | 64,833,000Source | 76,354,000Source | 99,497,000Source | 105,622,000Source |
| Selling and Marketing ExpenseUSD | — | — | 7,386,000Source | 6,654,000Source | 7,685,000Source | 7,048,000Source | 6,992,000Source | 7,374,000Source | 28,332,000Source | 31,231,000Source | 40,276,000Source | 37,438,000Source |
Offerings
Registration 333-236207
Registration 333-237737
Registration 333-252562
Registration 333-260267
Registration 333-262160
Registration 333-268863
Registration 333-273251
Registration 333-275862
Registration 333-278489
Registration 333-278561
Registration 333-282811
Registration 333-288215
Filing attachments
ef20063464_ex99-1.htm · 8-K · 2026-01-21
Exhibit 99.1 Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC TORONTO, January 21, 2026 (GLOBE NEWSWIRE) - Venus Concept Inc. (“Venus Concept” or the “Company”) announced today its voluntarily decision to delist its common stock from the NASDAQ Capital Market (“Nasdaq”) and deregister its common stock with the Securities and Exchange Commission (the “SEC”). The Company is in compliance with applicable Nasdaq listing requirements, but the Company’s Boar…
Read attachment ↗ef20058828_ex99-1.htm · 8-K · 2025-11-13
EX-99.1 2 ef20058828_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Venus Concept Announces Third Quarter 2025 Financial Results TORONTO, November 13, 2025 (GLOBE NEWSWIRE) - Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and nine months ended September 30, 2025. Summary of Financial Results & Recent Progress: Energy Based Device (“EBD”) revenues showing signs of stabilization. o …
Read attachment ↗ef20058828_ex99-2.htm · 8-K · 2025-11-13
EX-99.2 3 ef20058828_ex99-2.htm EXHIBIT 99.2 Exhibit 99.2 Venus Concept Receives 510(k) for the Venus NOVA, Its Most Advanced Multi-Application Platform for Non-Invasive Body and Skin Treatments Venus NOVA is the first product clearance from the Company’s new R&D strategy TORONTO, November 10, 2025 (GLOBE NEWSWIRE) - Venus Concept Inc. (“Venus Concept” or the “Company”), a global leader in medical aesthetic technology, announced today that it has received a 510(k) clearance from the U.S. …
Read attachment ↗ef20056518_ex99-1.htm · 8-K · 2025-10-02
EX-99.1 7 ef20056518_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Venus Concept Announces $11.48 Million Debt-to-Equity Exchange Transaction Reduction of outstanding debt by Madryn Asset Management continues to improve the Company’s financial position TORONTO, October 2, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on September 30, 2025, the Company exchanged the full $11.48 milli…
Read attachment ↗ef20053916_ex99-1.htm · 8-K · 2025-08-14
EX-99.1 2 ef20053916_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Venus Concept Announces Second Quarter 2025 Financial Results TORONTO, August 14, 2025 (GLOBE NEWSWIRE) - Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for the three and six months ended June 30, 2025. Summary of Financial Results & Recent Progress: Total revenue for the second quarter of $15.7 million, down 5% year-over-year and up…
Read attachment ↗ef20051445_ex99-1.htm · 8-K · 2025-07-01
EX-99.1 10 ef20051445_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 Venus Concept Announces $6.5 Million Debt-to-Equity Exchange Transaction Further reduction of outstanding debt by Madryn Asset Management improves the Company’s balance sheet position TORONTO, July 1, 2025 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that, on June 30, 2025, the Company exchanged $6.5 million of its subordinat…
Read attachment ↗